Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Inactivated Vaccines Market Grown from 2024 to 2025?

The market size for inactivated vaccines has witnessed a consistent growth in the past few years. It is projected to expand from $6.19 billion in 2024 to $6.44 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.0%. The progressive growth during the historical period can be linked to initiatives aimed at eradicating polio, influenza immunization programs, the emergence of new infectious diseases, and regulatory approvals.

What Growth Rate Is Anticipated for the Inactivated Vaccines Market in the Coming Years?

The market for inactivated vaccines is projected to experience consistent expansion in the forthcoming years. The estimated growth will reach $7.75 billion in 2029, with a compound annual growth rate (CAGR) of 4.7%. The expected growth during this forecast period can be credited to pandemic readiness, increased vaccine coverage, advancements in biomanufacturing, and health equity initiatives. Some significant trends anticipated during the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

Who Are the Leading Companies in the Inactivated Vaccines Market?

Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

What Are the Key Drivers of the Inactivated Vaccines Market?

The rise in infectious diseases is predicted to spur the expansion of the inactivated vaccine industry. Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, or parasites, can be transmitted from one individual to another and can generate an array of symptoms and health issues. Tuberculosis is an example of an infectious disease. Inactivated vaccines utilize non-living pathogens to prompt an immune response, effectively shielding from diseases such as polio, hepatitis A, and influenza. For instance, Centers for Disease Control and Prevention, a public health agency in the US, reported in November 2023 an increase in tuberculosis cases in the US from 8,320 in 2022 to 9,615 in 2023, showing a jump of 1,295 cases. Hence, the rising prevalence of infectious diseases is fueling the growth of the inactivated vaccine market. The escalation in immunization efforts is anticipated to drive forward the growth of the inactivated vaccines market. Immunization initiatives or programs are structured campaigns with the goal of vaccinating individuals or communities to shield them from certain infectious diseases. These growing efforts towards immunization significantly contribute to the inactivated vaccines sector. Intensified vaccination drives result in greater demand for inactivated vaccines, encouraging market expansion and prompting investments in research and development. For instance, according to the Switzerland-based intergovernmental organization, the World Health Organization, vaccines prevent the death of 4-5 million people worldwide each year by protecting against diseases such as hepatitis, diphtheria, tetanus, pertussis (whooping cough), measles, and polio. In 2022, about 84% of infants around the world received three doses of the polio vaccine. Simultaneously, it’s projected that 84% infants in nations using oral polio vaccine (OPV) received their first dose of inactivated polio vaccine (IPV) in the same year. Therefore, the escalating trend of immunization initiatives is fostering the growth of the inactivated vaccines market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

What Are the Key Market Segments in the Inactivated Vaccines Industry?

The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

What Are the Latest Trends in the Inactivated Vaccines Market?

To remain competitive in the market for inactivated vaccines, key companies are launching advanced and innovative products. These types of vaccines consist of deactivated virus particles, bacteria, or any other pathogens—these microorganisms are cultured and subsequently killed to eliminate their ability to cause diseases. For instance, GSK PLC, a biotechnology and pharmaceutical enterprise stationed in the UK, launched a novel inactivated vaccine called Shingrix in January 2022. This is designed to offer protection against shingles (Herpes zoster). Shingrix, a non-live, recombinant subunit vaccine, is given via intramuscular injection in two separate doses. Initially, the vaccine was meant for those aged 50 years and up, but it has since been offered to those aged 18 years and above who are more susceptible to shingles due to immunodeficiency or immunosuppression related to specific illnesses or treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

What Are the Key Regional Markets in the Inactivated Vaccines Industry?

North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13018

This Report Delivers Insight On:

1. How big is the inactivated vaccines market, and how is it changing globally?

2. Who are the major companies in the inactivated vaccines market, and how are they performing?

3. What are the key opportunities and risks in the inactivated vaccines market right now?

4. Which products or customer segments are growing the most in the inactivated vaccines market?

5. What factors are helping or slowing down the growth of the inactivated vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model